SILVERCEL™ is an antimicrobial hydroalginate dressing. Each non-woven pad uses a combination of alginate, carboxymethylcellulose (CMC) and nylon fibers coated with silver to absorb exudate, reduce bioburden and create a moist healing environment. At the same time, EASYLIFT™ technology provides a non-adherent contact layer that allows for painless, atraumatic removal.
How SILVERCEL™ Antimicrobial Alginate Dressings Work
To decrease the amount of bacteria present in the wound, hold onto exudate and streamline dressing changes without disturbing newly forming tissue, SILVERCEL™ antimicrobial alginate dressings feature the following:
EASYLIFT™ Technology
EASYLIFT™ Precision Film Technology improves dressing changes. Rather than have fibers stick or become loose, SILVERCEL™ dressings remain in one piece without adhering to the wound bed. This process won’t interrupt new tissue growth while allowing the dressing to continue absorbing a high amount of exudate.
Broad-Spectrum Antibacterial Action
Each SILVERCEL™ dressing delivers sustained release of silver ions for up to seven days. As this occurs, the dressing helps control a wide range of microorganisms and bacteria and lessen potential odors. At the same time, construction blocks out exterior pathogens that could invite infection and stall healing.
Encourages Wound Healing
Aiding multiple healing stages, SILVERCEL™ dressings absorb fluids from moderate- to high-exudate wounds while maintaining a moist environment.
Uses for SILVERCEL™ Antimicrobial Alginate Dressings
SILVERCEL™ dressings assist with healing partial- to full-thickness chronic and acute wounds, including:
• Pressure ulcers
• Venous ulcers
• Diabetic ulcers
• Donor sites
• Traumatic wounds
• Surgical wounds
• First- and second-degree burns
To use, apply a SILVERCELL™ dressing to the wound bed before covering with a secondary dressing.
Product: 900112
Product: 900202
Product: 900404
Product: 900408
This product is part of 3M’s comprehensive plan for the treatment of diabetic foot ulcers (DFU) and venous leg ulcers (VLU). Biofilm, present in greater than 70% of chronic wounds, causes persistent inflammation and poor wound healing. Wound bed preparation, including the management of biofilm, is an essential element in treating these often-stubborn conditions.
